XLY is trading an increasingly contradictory tape: shorts are rebuilding at a meaningful pace while the borrow market remains wide open — and now options traders are quietly joining the cautious side.
The short-interest story has shifted since the August 19 note described bears holding ground after a volatile mid-August reload. They have not held ground — they have added. Short interest climbed another 6% on the week to 11.57 million shares, representing 11.7% of the free float. That is the highest reading in the 30-day window, and the trend is unambiguous: from roughly 9.3 million shares in early August, the short book has grown more than 24% in three weeks. Bears who paused mid-month have resumed building.
The borrow market, however, is not cooperating with the bearish thesis as a near-term squeeze tool. Availability has tightened sharply — it fell 57% on the week from an extraordinarily loose 1,701% to a still-very-loose 728%. That is a meaningful directional shift, but it remains well within the normal range and nowhere near the sub-200% territory that would signal genuine squeeze pressure. Cost to borrow doubled on the week to 0.44%, which sounds dramatic but remains well below the levels seen in late July when CTB was near 0.64%. The message is that shorts can still add with ease. There are still roughly seven shares available in the lending pool for every one currently borrowed.
Options positioning has turned more defensive than usual, adding a new dimension to this week's setup. The put/call ratio hit 2.78 — its highest reading of the past month and well above its 20-day average of 2.53. At 1.7 standard deviations above that mean, the PCR is elevated but not extreme relative to the 52-week context, where readings have swung from 1.07 to a 42.0 spike that reflects the structural put-heavy nature of ETF hedging. Still, the week-on-week jump in the PCR — combined with the short-interest build — suggests institutional participants are adding downside protection through multiple channels simultaneously.
Institutional ownership reinforces the picture of a well-trafficked hedging vehicle. Managed Account Advisors holds 16.2% of shares and added 1.2 million shares in Q2. JPMorgan, Morgan Stanley, and Goldman all carry positions, with JPMorgan adding 292,000 shares and Goldman adding 131,000 in the most recent filing period. The buy-side activity here likely reflects the ETF's role as a sector hedge rather than directional conviction. UBS trimmed 811,000 shares in the same period — the one notable seller among the top holders.
The ORTEX short score has crept up to 41.6, a one-week high, and has risen every session since August 18. The ETF itself is up 7.8% over the past month, closing Tuesday at $117.95. Bears are therefore pressing a position against a rising market, at modest borrowing cost, with ample room to add — and options traders are providing the same hedging cover. What to watch next: whether the borrow availability continues its tightening trend toward the 200-500% range, and whether short interest pushes toward or through the 12% of float level that would match the tightest positioning of the past year.
See the live data behind this article on ORTEX.
Open XLY on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
